[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Life Sciences Market Research Reports & Industry Analysis

“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.

The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.

A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.

Publications found: 251,903
Sort by:

Future Microbiology Testing Market: Facilities, Test Volumes, and Sales Forecasts by Country

US$ 1,480.00

This report provides a worldwide overview of the microbiology testing market environment, structure, size and growth. Includes estimates of the number of laboratories performing microbiology tests, as well as ten-year test volume and sales forecasts by country. Contains 15 pages and 3 tables

February 2012 15 pages

Microbiology Testing Market: Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks

US$ 760.00

The report identifies the major opportunities for microbiology testing instrumentation, reagent kits/test panels, consumables, as well as IT and auxiliary products; proposes design criteria for decentralized testing products; suggests alternative market penetration strategies; and analyzes entry barriers and ...

February 2012 21 pages

Future French Microbiology Testing Market Outlook

US$ 4,720.00

Highlights Comprehensive 980-page analysis of the French microbiology testing market. Major issues pertaining to the French microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...

February 2012 980 pages

Future German Microbiology Testing Market Outlook

US$ 4,720.00

Highlights Comprehensive 983-page analysis of the German microbiology testing market. Major issues pertaining to the German microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...

February 2012 983 pages

Future Italian Microbiology Testing Market Outlook

US$ 4,720.00

Highlights Comprehensive 970-page analysis of the Italian microbiology testing market. Major issues pertaining to the Italian microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

February 2012 970 pages

Future Japanese Microbiology Testing Market Outlook

US$ 6,240.00

Highlights Comprehensive 976-page analysis of the Japanese microbiology testing market. Major issues pertaining to the Japanese microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

February 2012 976 pages

Future Spanish Microbiology Testing Market Outlook

US$ 4,720.00

Highlights Comprehensive 960-page analysis of the Spanish microbiology testing market. Major issues pertaining to the Spanish microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

February 2012 960 pages

Future UK Microbiology Testing Market Outlook

US$ 4,720.00

Highlights Comprehensive 978-page analysis of the UK microbiology testing market. Major issues pertaining to the UK microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...

February 2012 978 pages

Future US Microbiology Testing Market Outlook

US$ 7,520.00

Highlights Comprehensive 1,037-page analysis of the US microbiology testing market. Major issues pertaining to the US microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...

February 2012 1037 pages

DISHMAN - Result Does Not Change the Outlook

US$ 140.00

Dishman’s Q3 FY12 EBITDA was higher than our estimates owing to change in ... and Dishman Netherlands grew by 28% and 36% Y-o-Y respectively mainly due to a favorable forex. Carbogen remained flat in constant currency. In other words, this quarter does not ...

February 2012 5 pages

Growth Opportunities in Transfusion Diagnostic Testing

US$ 22,880.00

During the next ten years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of ... than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, ...

February 2012 800 pages

The Healthcare Packaging Market 2012-2022

US$ 2,635.00

... of analyses and forecasts. Why you should buy The Healthcare Packaging Market 2012-2022 You will receive a comprehensive analysis of the ... the outline and profile of 19 major companies operating within the healthcare packaging market. Chapter 9 is a summary of the report, outlining the conclusions of the ...

February 2012 158 pages

Emerging Transfusion Diagnostic Tests and Companies Developing Innovative Technologies and Products

US$ 2,000.00

... analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new transfusion testing technologies and products. Contains 186 pages and 7 tables

February 2012 186 pages

Future French Transfusion Diagnostic Testing Market Outlook

US$ 4,320.00

... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in French transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...

February 2012 430 pages

Future German Transfusion Diagnostic Testing Market Outlook

US$ 4,320.00

... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in German transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...

February 2012 426 pages

Future Italian Transfusion Diagnostic Testing Market Outlook

US$ 4,320.00

... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Italian transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...

February 2012 412 pages

Future Japanese Transfusion Diagnostic Testing Market Outlook

US$ 5,440.00

... next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Japanese transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi- ...

February 2012 426 pages

Future Spanish Transfusion Diagnostic Testing Market Outlook

US$ 4,320.00

... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Spanish transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...

February 2012 425 pages

Future UK Transfusion Diagnostic Testing Market Outlook

US$ 4,320.00

... ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in UK transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi-automated ...

February 2012 422 pages

Future US Transfusion Diagnostic Testing Market Outlook

US$ 7,120.00

Highlights Comprehensive 460-pages market segmentation analysis of the US transfusion testing market. Major issues pertaining to the US transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

February 2012 460 pages

CELGENE - Core Business + Pipeline Investments = Long Term Growth

US$ 140.00

Celgene (CELG) reported robust FY11 earnings, despite weak economies and ... detail, please read our report released on 10th Feb., 2012 on Celgene titled “CELGENE - Core Business + Pipeline Investments = Long Term Growth”.

February 2012 9 pages

GILEAD - Providing the Best Antiviral Treatment Options for HIV and HCV!

US$ 140.00

Gilead (GILD) is poised for further growth, based on the FY12 ... GILD a step closer towards its goal to deliver the “best-in-class IFN-free oral pill” for HCV. Other acquisitions ... read our report released on 10th Feb., 2012 on Gilead Sciences titled “Providing the Best Antiviral Treatment Options for HIV and HCV!”

February 2012 11 pages

U.S. Market for ENT and Bronchoscopic Devices 2012

US$ 7,495.00

... biopsy forcep and TBNA needle segments. Within the U.S. ENT and Bronchoscopic Device market, companies such as Arthrocare, Boston Scientific, Karl Storz, ... report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, ...

February 2012 310 pages

U.S. Market for Peripheral Vascular Devices 2012

US$ 7,495.00

... devices These devices can be used to treat either coronary arterial or peripheral arterial disease (PAD), but only those devices used for ... grow rapidly in the U.S. over the forecast period. Within the U.S. peripheral vascular market, companies such as Boston Scientific, Cordis, Cook Medical, C.R. Bard and ...

February 2012 307 pages

U.S. Market for Therapeutic Support Surfaces (TSS) 2012

US$ 7,495.00

... ulcer prevention and education on the benefits of TSS products, will help drive unit sales, rentals and the average selling price. In 2011, the bariatric beds ... the long term care and home care settings. Within the therapeutic support surfaces market, companies such as Hill-Rom, Stryker, KCI and Invacare led ...

February 2012 167 pages

CADILA HEALTHCARE - Costs Related To Acquisitions Pressurizing Margin

US$ 140.00

Cadila’s Q3 FY12 result was below our estimate largely due to higher ... . Given 3 acquisitions over last one year, we consider all these as costs of integration. Organic sales growth at 13% remains moderate despite a favorable currency ...

February 2012 5 pages

SANOFI - 4Q Results - No Surprises, Growth going forward will be Challenging

US$ 90.00

Sanofi announced its 4Q-2011 earnings, the revenue and EPS performance ...

February 2012 2 pages

Forecast Revisit 2011-2012: Consumer Health

US$ 2,000.00

... health trends behind the data. Euromonitor International’s Forecast Revisit 2011-2012: Consumer Health global briefing examines the size, growth trends and ... Supplements, Weight Management. Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. Why buy ...

February 2012 42 pages

DR REDDY’S LAB - Olanzapine and Forex Drive Growth

US$ 140.00

... on Dr Reddy’s after its Q3 FY12 result that was higher than our estimate only due to higher than expected generic Zyprexa (Olanzapine) sales ...

February 2012 5 pages

MERCK - Vorapaxar: Subgroup Analyses Hold the Key: TRA-2P study Met Primary Endpoint

US$ 90.00

Merck today announced the topline results from much awaited Vorapaxar clinical study in secondary prevention of heart attack and stroke (TRA-2P). Addition of Vorapaxar to standard ... TRA-2P with external experts to help better understand the profile of Vorapaxar in specific patient populations.

February 2012 2 pages

Manual Wheelchair Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018

US$ 3,700.00

WinterGreen Research announces that it has a new study on Manual Wheelchair Market Shares and Forecasts, Worldwide, 2012-2018. The 2012 study ... markets achieving 49% market share in 2011, increasing its share by several percent in the total market as a result of good marketing, execution of sales strategy, and ...

February 2012 365 pages

Handhelds in Healthcare: The World Market for PDAs, Tablet PCs, Handheld Monitors & Scanners

US$ 3,500.00

... and mandates for EMR usage, has made handhelds ubiquitous in healthcare worldwide. Increasingly healthcare providers are using devices that can ... and order services on a mobile basis. This Kalorama Information report - Handhelds in Healthcare - represents Kalorama's second edition of its review of the market ...

February 2012 180 pages

Indian Healthcare - New Avenues for Growth

US$ 800.00

In India, delivering an affordable healthcare to billion-plus population presents enormous challenges and opportunities for the medical community. The past decade has seen the country’s healthcare sec...

February 2012 90 pages

India Commercial Vehicle Market Analysis

US$ 800.00

Two decades ago, India opened its doors for multinational automobile companies allowing them to penetrate the market, modernize the Indian transportation picture and make it beneficial for the end-use...

February 2012 80 pages

Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts)

US$ 2,500.00

... market over the past ten years suggests the amount of vaccine production and the techniques of vaccine production will need to adapt to match a revived industry. This report, Vaccine Production (Trends, Techniques, Key Players, Spending Estimates and Forecasts) examines the market for ...

February 2012 180 pages

World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)

US$ 3,800.00

This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, ...

February 2012 220 pages

Insulin Delivery Systems Market Forecast to 2014

US$ 1,400.00

The global medical fraternity is alarmed at the rate at which the diabetic population has been increasing worldwide. It is expected that the number of diabetic patients in the world will reach around...

February 2012 90 pages

Japan Generics Market Analysis

US$ 1,000.00

Japan is the world’s second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained low in it. However, worried over rising healthcare expens...

February 2012 55 pages

Global Heart Valve Market Report: 2011 Edition

US$ 800.00

... obesity are the major factors which are driving the global heart valve market growth. Moreover, rising urban population which leads ... report provides an analysis of the global heart valve market. It also discusses the major trends, growth drivers and potential markets for heart valve market. The report ...

February 2012 35 pages

Canada’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis

US$ 175.00

... is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes ... the world’s citizens. Aruvian's R'search analyzes the Canadian Biotechnology industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in ...

February 2012 20 pages

Japan’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis

US$ 175.00

... is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes ... the world’s citizens. Aruvian's R'search analyzes the Japanese Biotechnology Industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in ...

February 2012 20 pages

Drug Industry in the United States - Porter’s Five Forces Strategy Analysis

US$ 175.00

... falling, leading to layoffs and cuts in research budgets. While the US drug industry is hardly in a full-blown crisis, however, layoffs are occurring ... taken once a week instead of daily. Aruvian's R'search analyzes the United States Drug Industry in the Michael Porter’s Five Forces Analysis. It uses concepts ...

February 2012 12 pages

Analyzing the Global Pharmaceutical Industry

US$ 450.00

... corporate enterprises. Aruvian's R'search’s report – Analyzing the Global Pharmaceutical Industry - presents a complete analysis of the global pharmaceutical industry by setting up a industry demarcation and ...

February 2012 480 pages

Looking at Bioinformatics – IT’s Human Touch

US$ 275.00

... ranging industries and research applications. The growing acceptance of Bioinformatics as an important field requiring focused commercial support and ... in order to expand the service bases. Aruvian's R'search’s report – Looking at Bioinformatics – IT’s Human Touch - is a analytical docket on the Bio Informatics ...

February 2012 85 pages

Pharmaceutical Industry in China

US$ 325.00

... the government in the industry, and investment opportunities in China’s Pharmaceutical Industry. Complete with a comprehensive section on the clinical ... players in the Chinese Pharmaceutical Industry, Aruvian’s latest research is a collection of all you need to know about China’s Pharmaceutical Industry.

February 2012 80 pages

Pharmaceutical Industry in China – PEST Framework Analysis

US$ 175.00

... manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and ... competitiveness, coupled with a lack of patented pharmaceuticals developed in-house. Aruvian's R'search analyzes Pharmaceutical Industry in China in a PEST Framework Analysis. A PEST ...

February 2012 25 pages

Pharmaceutical Industry in Mexico

US$ 325.00

... cellular and molecular levels to dramatically advance the treatment of disease. Mexico’s pharmaceutical policy environment is in a period of rapid evolution, with simultaneous policy development ...

February 2012 120 pages

Pharmaceutical Industry in Poland

US$ 300.00

... on healthcare as economies boomed globally. The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D ... of hospitalization. Aruvian’s R’search brings you a complete analysis of the Pharmaceutical Industry in Denmark. The report covers a brief profile of the global ...

February 2012 100 pages

Pharmaceutical Industry in Denmark

US$ 300.00

... a complete analysis of the Pharmaceutical Industry in Denmark. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Denmark – complete with a SWOT analysis of the leading companies in ...

February 2012 100 pages

Pharmaceutical Industry in Sweden

US$ 300.00

... a complete analysis of the Pharmaceutical Industry in Sweden. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Sweden – complete with a SWOT analysis of the leading companies in ...

February 2012 100 pages

Filters

Search

Categories

57
23,523
370
94
953
914
541
405
240
22
8,560
251
675
84
1,065
4
507
19
242
547
553
305
23
177
39
32,726
40
139
353
702
23
152
69
5,323
96
1,835
167
49
819
116
1,161
657
550
1,863
4,251
1,143
70
110,057
509
48,769
94

Publishers

251
21
1
4
204
62
259
245
2
816
79
698
53
68
583
106
6,695
6,889
30,350
501
2,379
5,841
1
3
1
1
484
7
1,083
7,758
450
142
448
1
2,189
1
136
9
1,696
8
29
79
5
2
75
11,736
2,327
698
6
10,807
171
1
321
1,034
1
33,621
484
66
5
5
214
2
1,360
5,811
151
56
481
149
148
214
3,604
3
4
536
197
15
23
3
107
22
19,652
31
31
1
16
89
9,602
54
143
74
807
1
1,261
2,133
48
220
29
5
11,194
2
45
173
10
108
5
482
11
33
21
160
348
36
110
436
2
89
186
8
313
5
3
382
4
118
58
53
61
8
20
119
111
2
9
1
1,733
1
13
8
5
492
1
1
15
1
37
2
3
28
7
3
1
206
7
1
306
6
368
3
273
51
42,926
140
1
2
4
114
2
16
9
43
26
1
212
3
9
4
22
1
2,327
3,742
1
2
3
220
400
78
689
964
388
206
160
8
47
32
328
38
4
1,128
7

Regions

247
231
217
215
215
200
198
197
196
156
154
140
140
140
136
136
131
19
18
17
17
15
11
10
7
6
5
5
4
4
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
260
39
158
6,404
1,656
1,551
1,417
1,388
1,371
1,369
349
334
320
304
302
292
291
283
278
276
274
274
273
272
271
271
270
268
267
265
265
264
263
261
261
259
255
254
254
253
252
249
242
232
226
226
221
203
196
194
190
181
161
151
67
36
33
26
14
2
134
131
5,388
317
290
285
7,450
3,586
412
198
114
181,288
208
191
195
477
476
306
294
271
249
155
175
32
242
173
163
155
236
193
17
143
32
238
36
4,814
4,304
8,014

Price

Date

Pages

Offers

254
112
1
380
7
5
17